IRIS
BONATI, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.265
AS - Asia 3.106
EU - Europa 1.998
SA - Sud America 295
AF - Africa 138
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.810
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.169
SG - Singapore 1.091
CN - Cina 1.005
VN - Vietnam 426
IT - Italia 362
IE - Irlanda 310
SE - Svezia 273
FI - Finlandia 260
DE - Germania 242
BR - Brasile 231
UA - Ucraina 216
HK - Hong Kong 203
TR - Turchia 109
BD - Bangladesh 100
NL - Olanda 96
ZA - Sudafrica 86
CA - Canada 75
FR - Francia 64
GB - Regno Unito 53
IN - India 39
JP - Giappone 38
RU - Federazione Russa 29
CI - Costa d'Avorio 27
AR - Argentina 24
AT - Austria 16
ES - Italia 16
BE - Belgio 15
IQ - Iraq 13
KR - Corea 13
EC - Ecuador 12
MX - Messico 11
PL - Polonia 9
CZ - Repubblica Ceca 8
ID - Indonesia 8
CL - Cile 7
LT - Lituania 7
MA - Marocco 7
PK - Pakistan 7
SA - Arabia Saudita 7
AU - Australia 6
VE - Venezuela 6
BO - Bolivia 4
CO - Colombia 4
DZ - Algeria 4
EE - Estonia 4
IR - Iran 4
JO - Giordania 4
KG - Kirghizistan 4
PH - Filippine 4
PT - Portogallo 4
PY - Paraguay 4
TW - Taiwan 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
KE - Kenya 3
RO - Romania 3
TN - Tunisia 3
AM - Armenia 2
CH - Svizzera 2
LV - Lettonia 2
LY - Libia 2
MN - Mongolia 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
MZ - Mozambico 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.810
Salva come PNG Salva come JPEG
Città #
Singapore 536
San Jose 335
Chandler 326
Jacksonville 322
Dublin 309
Ashburn 282
Beijing 263
Santa Clara 257
Hong Kong 193
Dallas 149
Nanjing 116
Ho Chi Minh City 112
Boardman 106
Ann Arbor 105
Hanoi 105
Parma 98
Izmir 91
Dearborn 87
Johannesburg 84
San Mateo 71
Princeton 70
Los Angeles 58
Lauterbourg 55
New York 52
Toronto 50
Jinan 49
Wilmington 47
Hebei 41
Munich 41
Shenyang 40
Bologna 39
Hefei 36
Tokyo 36
Shanghai 32
Helsinki 31
Des Moines 30
Nanchang 30
Abidjan 27
Kunming 27
São Paulo 27
Moscow 26
Da Nang 23
Columbus 21
Changsha 19
Council Bluffs 19
Guangzhou 19
Düsseldorf 18
Haiphong 18
Milan 17
Woodbridge 17
Tianjin 16
Brussels 15
Montreal 15
Buffalo 14
Turku 14
Zhengzhou 14
Amsterdam 13
London 13
Nuremberg 13
Pittsburgh 13
Falls Church 12
Fremont 11
Grafing 11
Haikou 11
Atlanta 10
Chennai 10
Kocaeli 10
Orem 10
Rio de Janeiro 10
Seattle 10
Taizhou 10
The Dalles 10
Brooklyn 9
Hải Dương 9
Jiaxing 9
Lanzhou 9
Leawood 9
Rome 9
Vienna 9
Denver 8
Fuzhou 8
Houston 8
Seoul 8
Warsaw 8
Baghdad 7
Boston 7
Bremen 7
Chengdu 7
Hangzhou 7
Poplar 7
Redmond 7
Trezzano Sul Naviglio 7
Biên Hòa 6
Borås 6
Can Tho 6
Chicago 6
Falkenstein 6
Frankfurt am Main 6
Modena 6
Naples 6
Totale 5.434
Salva come PNG Salva come JPEG
Nome #
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 311
MEK1/2 KINASES DISABLE THE TUMOR SUPPRESSOR FUNCTIONS OF NATIVE BCR AND ABL1 KINASES TO IMPAIR ANTICANCER DRUGS’ RESPONSIVENESS IN TKI-RESISTANT PHILADELPHIA POSITIVE LEUKEMIAS 261
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH+-LEUKEMIA 255
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activity. 168
Early proinflammatory activation of renal tubular cells by normal and pathologic IgG 155
Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL 154
Elevated telomerase activity, minimal telomere loss in cord blood long-term cultures with extensive stem cell replication 153
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 147
The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-1{alpha} activity being involved in myeloma-induced angiogenesis. 143
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH plus -LEUKEMIA 141
Biochemical, Immunological, and Molecular Markers of Hemopoietic Precursor Cells. 140
p73 and p53 pathway in human breast cancers. 139
Treatment with Arsenic Trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells 136
Targeting the cancer initiating cell: the ultimate target for cancer therapy. 135
A micro-mechanically motivated model for the strength of heat-treated glass 132
Emerging MEK inhibitors 131
Arsenic Trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells 128
T cell receptor genes: a glance at normal and malignant hematopoiesis. 127
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent anti-tumor activity in vivo against human multiple myeloma xenograft model. 125
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts 125
Emerging Raf inhibitors 124
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. 124
Lung cancer in patients with chronic lymphocytic leukemia: does the HER-2 oncogene play a role? 121
MDM2 inhibition synergistically enhances cytotoxicity of MEK1 inhibitor and Arsenic Trioxide (ATO) in AML blasts that retain a functional p53 pathway 121
Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterization. 121
Arsenic Trioxide in hematological malignancies: the new discovery of an ancient drug. 120
Discordant expression of terminal transferase and T cell receptor beta chain in fetal and pediatric thymocytes. 120
Terminal deoxynucleotidyl transferase (TdT) levels in hairy cell leukemia. 119
Calibration of the Statistical-Interference Factors for the Design of Tempered Structural Glass 118
Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells. 118
BCL2 oncogene protein expression in human hematopoietic precursors during fetal life. 118
Ph1-positive acute myelocytic leukemia with high TdT levels. 118
Pan-aurora kinase inhibitor MK-0457 synergistically potentiates Apo2l/TRAIL cytotoxicity in Multiple Mieloma cells sensitive and resistant to bortezomib 118
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia 117
Su di un caso di sclerodermia associato ad aplasia midollare globale. 114
T-cell receptor beta-chain gene rearrangement and expression during human thymic ontogenesis. 113
Human T-cell receptor alpha chain gene during ontogeny 113
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts. 112
Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein. 112
MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors 110
Synthesis, characterisation, X-ray structure and biological activity of three new 5-formyluracil thiosemicarbazone complexes 107
Espressione degli antigeni CD1a, CD1b, CD1c in timo umano a diverse eta' dello sviluppo. 105
Terminal deoxynucleotidyl transferase: a nuclear marker of hemopoietic precursors. Biochemical, immunological and clinical aspects. 105
Expression of TCR beta chain gene N-diversity is not an early event in human thymic ontogeny 103
Synthesis, structure, spectroscopic properties and biological activity of mixed diorganotin(IV) complexes containing pyridine-2-carbaldehyde thiosemicarbazonato and diphenyldithiophosphinato ligands. 102
Synthesis, spectroscopic characterization and biological properties of new natural aldehydes thiosemicarbazones 101
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia 100
Hemopoiesis during human fetal life. Present knowledge and future prospects. 100
Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4. 100
La linfoadenopatia angio-immunoblastica: Osservazioni cliniche, patologiche ed immunologiche su di un caso. 98
Valutazione dell'attivita proliferativa delle cellule emopoietiche nelle sindromi preleucemiche. 97
Phorbol ester-induced PKC{epsilon} down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiation. 97
Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers. 96
Terminal deoxynucleotidyl transferase (TDT) expression correlates with the presence of N regions during human thymic ontogeny 95
La mielofibrosi idiopatica asplenomegalica. Osservazioni cliniche e considerazioni su cinque casi. 94
The fine structure of HNK-1 (Leu7) positive cells. A study using an immunoperoxidase technique. 94
Phenotype of the terminal transferase-positive cells in human foetal liver and bone-marrow: analysis with monoclonal antibodies. 94
Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways 94
Targeting the Raf/MEK/ERK pathway with small-molecule inhibitors. 94
Terminal deoxynucleotidyl transferase in human fetal tissues. 93
Terminal deoxynucleotidyl transferase-positive B cell precursors in fetal lymph nodes and extrahemopoietic tissues. 92
TCR beta chain expression during human thymic development. 91
Philadelphia-positive chronic myelogenous leukemia with typical bcr/abl molecular features and atypical, prolonged survival. 90
The combination of MEK inhibitors and Arsenic Trioxide triggers in vitro and in vivo synergistic cytotoxicity in multiple myeloma through multiple signaling pathways 88
MEK1 inhibition sensitizes primary acute myelogenous leukemia to arsenic trioxide-induced apoptosis 84
Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukaemia with unusual phenotype. 83
Selective Expression and Constitutive Phosphorylation of SHC Proteins in the CD34+ Fraction of Chronic Myelogenous Leukemias. 82
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. 82
Terminal deoxynucleotidyl transferase (TdT) in human foetuses. An immunofluorescent and biochemical study. 79
Leu-7-positive cells with monocyte phenotype show different ultrastructural features in comparison to Leu-7-positive cells with T-cell phenotype. 78
Medicina molecolare: nuovi strumenti per la conoscenza e la cura delle patologie dell'uomo. 76
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. 75
Regulation of proliferation and cytokine expression of bone marrow fibroblasts: role of c-myb. 75
The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting. 73
Combined Treatment with the Mek Inhibitor PD0325901 and Arsenic Trioxide Has Potent Antitumor Activity in Vivo against Human Multiple Myeloma Xenograft Model 53
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent antitumor activity in NOD-SCID mice bearing advanced tumors of human multiple myeloma. 47
THE COMBINATION OF MEK INHIBITORS AND ARSENIC TRIOXIDE TRIGGERS IN VITRO AND IN VIVO SYNERGISTIC CYTOTOXICITY IN MULTIPLE MYELOMA THROUGH MULTIPLE SIGNALING PATHWAYS 35
Arsenic Trioxide (ATO) Interacts Synergistically with MEK Inhibitors to Induce Apoptosis in STI571-Resistant Bcr-Abl Mutants 34
Totale 8.843
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.676
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/2022380 5 10 0 14 12 16 63 72 20 34 18 116
2022/20231.154 138 121 92 86 102 121 5 67 372 14 28 8
2023/2024402 33 47 17 7 54 68 23 9 15 22 34 73
2024/20251.590 59 91 104 60 208 197 30 74 215 138 114 300
2025/20263.114 281 273 343 243 390 202 409 135 388 220 161 69
Totale 8.843